Largest pharmaceuticals by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Johnson & Johnson leads the 61 pharmaceuticals ranked by cash on hand, at $19.7B, ahead of Merck & Co ($14.6B) and Novartis ($11.4B). Figures as of 18 Nov 2026, 13:49 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
Johnson & Johnson$19.7B
Median
$573.3M
Combined market value
$5.16T
Countries
10

Market values as of .

Largest pharmaceuticals by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Johnson & JohnsonJNJ · Health Care$19.7B$670.9B$278.70 1.36% down 38% up United States
2Merck & CoMRK · Health Care$14.6B$353.4B$143.37 0.75% down 51% up United States
3NovartisNVS · Health Care$11.4B$300.5B$159.13 0.67% down 25% up Switzerland
4Bristol-Myers SquibbBMY · Health Care$10.2B$125.4B$61.35 2.51% down 34% up United States
5Abbott LaboratoriesABT · Health Care$8.5B$181.4B$104.71 2.55% down 17% down United States
6SanofiSNY · Health Care$8.5B$114.1B$47.53 1.78% down 4% down France
7Eli LillyLLY · Health Care$7.3B$1.26T$1,415.55 1.13% down 35% up United States
8AstraZenecaAZN · Health Care$5.7B$282.7B$182.27 0.95% down 2% up United Kingdom
9AbbVieABBV · Health Care$5.2B$517.6B$292.82 0.59% down 26% up United States
10Vertex PharmaceuticalsVRTX · Health Care$5.1B$135.4B$534.20 0.67% down 27% up United States
11BeOne MedicinesONC · Health Care$4.5B$47.2B$413.26 0.48% up 17% up Switzerland
12GSKGSK · Health Care$4.5B$98.7B$49.24 2.32% down 6% up United Kingdom
13Novo NordiskNVO · Health Care$3.9B$179.4B$40.70 2.16% down 17% down Denmark
14Takeda PharmaceuticalTAK · Health Care$3.7B$69.1B$21.64 0.23% up 54% up Japan
15Teva Pharmaceutical IndustriesTEVA · Health Care$3.6B$49.7B$42.62 0.12% up 74% up Israel
16Regeneron PharmaceuticalsREGN · Health Care$3.1B$99.1B$957.76 0.56% up 36% up United States
17ZoetisZTS · Health Care$2.3B$33.9B$83.48 1.08% down 29% down United States
18GenmabGMAB · Health Care$1.7B$32B$51.96 0.76% up 70% up Denmark
19Alnylam PharmaceuticalsALNY · Health Care$1.7B$21B$156.50 2.02% down 66% down United States
20United TherapeuticsUTHR · Health Care$1.6B$24.9B$584.10 0.64% down 23% up United States
21Roivant SciencesROIV · Health Care$1.4B$28B$38.71 0.26% up 90% up United Kingdom
22Jazz PharmaceuticalsJAZZ · Health Care$1.4B$15.5B$240.71 0.39% up 37% up Ireland
23ViatrisVTRS · Health Care$1.3B$23.4B$20.45 1.40% down 96% up United States
24BioMarin PharmaceuticalBMRN · Health Care$1.3B$11.3B$58.51 0.90% up 11% up United States
25PfizerPFE · Health Care$1.1B$162.3B$28.47 1.35% down 14% up United States
26PTC TherapeuticsPTCT · Health Care$984.6M$5B$60.36 1.00% down 20% down United States
27GrifolsGRFS · Health Care$915.3M$5.9B$8.63 1.15% down 1% up Spain
28Legend BiotechLEGN · Health Care$901.9M$3.1B$16.11 0.75% up 42% down United States
29Ascendis PharmaASND · Health Care$683.5M$17.8B$271.19 0.20% down 28% up Denmark
30Royalty PharmaRPRX · Health Care$618.7M$39.5B$68.68 0.23% up 78% up United States
31ABIVAXABVX · Health Care$573.3M$7.2B$82.10 1.81% down 27% down France
32BridgeBio PharmaBBIO · Health Care$570.1M$15B$76.80 0.72% down 17% up United States
33Elanco Animal HealthELAN · Health Care$545M$12.9B$25.85 2.12% down 20% up United States
34InsmedINSM · Health Care$510.4M$26.7B$121.86 0.83% down 40% down United States
35AlkermesALKS · Health Care$388.6M$7.6B$45.45 2.32% down 58% up Ireland
36Ionis PharmaceuticalsIONS · Health Care$372.3M$4.5B$26.96 3.75% down 64% down United States
37Praxis Precision MedicinesPRAX · Health Care$357.3M$8.5B$305.06 1.68% down 61% up United States
38Belite BioBLTE · Health Care$352.9M$6.4B$157.72 2.98% down 31% up United States
39Axsome TherapeuticsAXSM · Health Care$322.9M$7.2B$135.95 0.77% down 7% down United States
40Cogent BiosciencesCOGT · Health Care$312M$4.8B$27.85 1.49% up 20% down United States
41Mirum PharmaceuticalsMIRM · Health Care$296.7M$6B$91.95 0.40% up 31% up United States
42Amneal PharmaceuticalsAMRX · Health Care$282M$7.4B$21.12 0.52% down 83% up United States
43Definium TherapeuticsDFTX · Health Care$257.8M$4B$29.38 2.59% down 169% up United States
44Arrowhead PharmaceuticalsARWR · Health Care$226.5M$6.1B$42.99 2.76% down 10% up United States
45Summit TherapeuticsSMMT · Health Care$225.3M$8.5B$10.67 9.73% down 36% down United States
46Madrigal PharmaceuticalsMDGL · Health Care$198.7M$9.8B$421.99 0.46% down 24% down United States
47Ligand PharmaceuticalsLGND · Health Care$174.9M$5.9B$293.81 2.62% down 43% up United States
48Kiniksa Pharmaceuticals InternationalKNSA · Health Care$165.6M$7.5B$95.11 0.93% up 126% up United Kingdom
49Dr. Reddy's LaboratoriesRDY · Health Care$163.5M$12.3B$14.79 0.61% up 5% up India
50Protagonist TherapeuticsPTGX · Health Care$128.4M$8.1B$124.67 0.13% down 46% up United States
51CytokineticsCYTK · Health Care$122.5M$7.2B$51.65 2.86% down 20% down United States
52Corcept TherapeuticsCORT · Health Care$120.5M$7.7B$70.07 1.23% up 8% down United States
53Travere TherapeuticsTVTX · Health Care$93M$4.9B$51.10 2.82% up 44% up United States
54Spyre TherapeuticsSYRE · Health Care$85.7M$8.9B$93.81 5.60% down 286% up United States
55TG TherapeuticsTGTX · Health Care$79.1M$9.5B$62.71 0.08% down 107% up United States
56ErascaERAS · Health Care$73.8M$4.9B$13.89 8.07% down 403% up United States
57Edgewise TherapeuticsEWTX · Health Care$61.1M$4.6B$42.04 3.75% down 88% up United States
58Rhythm PharmaceuticalsRYTM · Health Care$54.3M$8.1B$116.61 8.49% up 13% up United States
59Dianthus TherapeuticsDNTH · Health Care$51.1M$4.9B$86.98 2.87% down 113% up United States
60Oruka TherapeuticsORKA · Health Care$46.9M$6.5B$96.32 2.94% down 241% up United States
61VeradermicsMANE · Health Care$21.8M$5.3B$125.64 1.88% down 233% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceuticals rank first by cash on hand?

Johnson & Johnson ($19.7B), Merck & Co ($14.6B) and Novartis ($11.4B) are the top three of the 61 pharmaceuticals ranked by cash on hand as of 18 Nov 2026, 13:49 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by cash on hand.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by cash on hand have a combined market value of $5.16T as of 18 Nov 2026, 13:49 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest pharmaceuticals by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.